2004Nuclear TechniquesRequires access

Preparation of ~(99)Tc~m-DTPA-Folate and biodistribution study in athymic mice

Zhu Jian-hua

Open publisher page 0 citations

Abstract

The purpose of this article is to study the preparation and biodistribution of Tcm-DTPA-folate in nude 99 mice with a human tumor cell implant. DTPA-folate was synthesized by conjugating folic acid to diethylenetriaminepentaacetic(DTPA), then radiolabeled with 99Tcm. The radio-chemical purity and stability were evaluated. The biodistribution of Tcm-DTPA-folate in nude mice with a human tumor cell implant was studied. The 99 result showed that the radiolabelling yield of Tcm-DTPA-folate was as high as 98%. After 4 h at room temperature, 99 the radiochemical purity of Tcm-DTPA-folate was still over 90%. Tcm-DTPA-folate conjugation showed marked 99 99 tumor-specific deposition in vivo. The tumor-to-muscle ratio at 8 h post intraperitoneal injection was 7.5. 99Tcm-DTPA-folate appears to be a potential radiopharmaceutical for targeting tumor-associated folate receptor.

About this research paper

What this paper is about

The purpose of this article is to study the preparation and biodistribution of Tcm-DTPA-folate in nude 99 mice with a human tumor cell implant. DTPA-folate was synthesized by conjugating folic acid to diethylenetriaminepentaacetic(DTPA), then radiolabeled with 99Tcm. The radio-chemical purity and stability were evaluated. The biodistribution of Tcm-DTPA-folate in nude mice with a human tumor cell implant was studied. The 99 result showed that the radiolabelling yield of Tcm-DTPA-folate was as high as 98%. After 4 h at room temperature, 99 the radiochemical purity of Tcm-DTPA-folate was still over 90%. Tcm-DTPA-folate conjugation showed marked 99 99 tumor-specific deposition in vivo. The tumor-to-muscle ratio at 8 h post intraperitoneal injection was 7.5. 99Tcm-DTPA-folate appears to be a potential radiopharmaceutical for targeting tumor-associated folate receptor.

Why it matters

A significance statement is not available in the OpenAlex record.

Key contribution

A contribution statement is not available in the OpenAlex record.

Method / approach

Method details are not available in the OpenAlex metadata.

Main findings

Findings are not separately available in the OpenAlex metadata.

Limitations

Limitations are not available in the OpenAlex metadata.

Applications

Application details are not available in the OpenAlex metadata.

Available abstract

The purpose of this article is to study the preparation and biodistribution of Tcm-DTPA-folate in nude 99 mice with a human tumor cell implant. DTPA-folate was synthesized by conjugating folic acid to diethylenetriaminepentaacetic(DTPA), then radiolabeled with 99Tcm. The radio-chemical purity and stability were evaluated. The biodistribution of Tcm-DTPA-folate in nude mice with a human tumor cell implant was studied. The 99 result showed that the radiolabelling yield of Tcm-DTPA-folate was as high as 98%. After 4 h at room temperature, 99 the radiochemical purity of Tcm-DTPA-folate was still over 90%. Tcm-DTPA-folate conjugation showed marked 99 99 tumor-specific deposition in vivo. The tumor-to-muscle ratio at 8 h post intraperitoneal injection was 7.5. 99Tcm-DTPA-folate appears to be a potential radiopharmaceutical for targeting tumor-associated folate receptor.

Key concepts: Biodistribution, Folate receptor, Chemistry, In vivo, Radiochemistry, Folic acid, Tissue distribution, Nuclear medicine

Related papers

Back to paper searchBrowse research topicsOriginal source
Preparation of ~(99)Tc~m-DTPA-Folate and biodistribution study in athymic mice — Research Paper | ScholarLens